Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

ASPIRIN AND DIPYRIDAMOLE

ASPIRIN; DIPYRIDAMOLE

Standard Dose
25MG;200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ASPIRIN AND DIPYRIDAMOLE is listed in Drugs@FDA under application 210318 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ASPIRIN; DIPYRIDAMOLE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG Sponsor GLENMARK SPECLT Submission history Latest submission status date: 2021-11-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview ASPIRIN AND DIPYRIDAMOLE is listed in Drugs@FDA under application 210318 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ASPIRIN; DIPYRIDAMOLE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG Sponsor GLENMARK SPECLT Submission history Latest submission status date: 2021-11-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.